Presentation and management of acute coronary syndromes among adult persons with haemophilia: Results of an international, retrospective, 10-year survey

Haemophilia

Volumn 21, Issue 5, 2015, Pages 589-597

  Fogarty, P F ^a   Mancuso, M E ^b   Kasthuri, R ^c   Bidlingmaier, C ^d   Chitlur, M ^e   Gomez, K ^f   Holme, P A ^g   James, P ^h   Kruse Jarres, R ⁱ   Mahlangu, J ^j   Mingot Castellano, M E ^k   Soni, A ^l  

^a Penn Comprehensive Hemophilia and Thrombosis Program   (United States)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d Munich Hemophilia Center   (Germany)

^e CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^f ROYAL FREE HOSPITAL   (United Kingdom)

^g OSLO UNIVERSITY HOSPITAL   (Norway)

^h QUEEN S UNIVERSITY   (Canada)

ⁱ TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^k HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^l CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

more..

Author keywords

Acute coronary syndrome; Antiplatelet therapy; Cardiovascular disease; Haemophilia; Myocardial infarction; Stent

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT; HEMOSTATIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DISEASE ASSOCIATION; DISEASE SEVERITY; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HEMOPHILIA; HEMOPHILIA A; HUMAN; MIDDLE AGED; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; CHRONIC DISEASE; COMPLICATION; INTERNATIONAL COOPERATION;

ACUTE CORONARY SYNDROME; ADULT; AGED; CHRONIC DISEASE; CORONARY ARTERY BYPASS; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEMOPHILIA A; HEMOSTATICS; HUMANS; INTERNATIONALITY; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; RETROSPECTIVE STUDIES;

EID: 84942199779     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/hae.12652     Document Type: Article

References (23)

1. Foley CJ, Nichols L, Jeong K, Moore C, Ragni MV. Coronary atherosclerosis and cardiovascular mortality in hemophilia. J Thromb Haemost 2010; 8: 208-11.
2. Tuinenburg A, Rutten A, Kavousi M etal. Coronary artery calcification in hemophilia A: no evidence for a protective effect of factor VIII deficiency on atherosclerosis. Arterioscler Thromb Vasc Biol 2011; 32: 799-804.
3. Sramek A, Reiber JH, Gerrits WB, Rosendaal FR. Decreased coagulability has no clinically relevant effect on atherogenesis: observations in individuals with a hereditary bleeding tendency. Circulation 2001; 104: 762-7.
4. Darby SC, Kan SW, Spooner RJ etal. Mortality rates, life expectancy, and causes of death in people with hemophilia A or B in the United Kingdom who were not infected with HIV. Blood 2007; 110: 815-25.
5. Plug I, Van Der Bom JG, Peters M etal. Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. J Thromb Haemost 2006; 4: 510-6.
6. Tagliaferri A, Franchini M, Coppola A etal. Effects of secondary prophylaxis started in adolescent and adult haemophiliacs. Haemophilia 2008; 14: 945-51.
7. Triemstra M, Rosendaal FR, Smit C, Van der Ploeg HM, Briet E. Mortality in patients with hemophilia. Changes in a Dutch population from 1986 to 1992 and 1973 to 1986. Ann Intern Med 1986; 1995: 823-7.
8. Anderson JL, Adams CD, Antman EM etal. 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation 2013; 127: e663-828.
9. O'Gara PT, Kushner FG, Ascheim DD etal. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2013; 61: 485-510.
10. Alesci S, Krekeler S, Seifried E, Miesbach W. Platelet inhibition and bleeding complications in patients with haemophilia/von Willebrand's disease and coronary artery disease. Haemophilia 2012; 18: e364-5.
11. Tang M, Wierup P, Terp K, Ingerslev J, Sorensen B. Cardiac surgery in patients with haemophilia. Haemophilia 2009; 15: 101-7.
12. Mannucci PM. Management of antithrombotic therapy for acute coronary syndromes and atrial fibrillation in patients with hemophilia. Expert Opin Pharmacother 2012; 13: 505-10.
13. Mannucci PM, Schutgens RE, Santagostino E, Mauser-Bunschoten EP. How I treat age-related morbidities in elderly persons with hemophilia. Blood 2009; 114: 5256-63.
14. Schutgens REG, Tuinenburg A, Roosendaal G, Hoseyni GS, Mauser-Bunschoten EP. Treatment of ischaemic heart disease in haemophilia patients: an institutional guideline. Haemophilia 2009; 15: 952-8.
15. James P, Kasthuri R, Kruse-Jarres R etal. Global Emerging HEmophilia Panel (GEHEP): a multinational collaboration for advancing hemophilia research and treatment. Transfus Med Hemother 2013; 40: 352-5.
16. Srivastava A, Brewer AK, Mauser-Bunschoten EP etal. Guidelines for the management of hemophilia. Haemophilia 2013; 19: e1-47.
17. Tuinenburg A, Damen SA, Ypma PF, Mauser-Bunschoten EP, Voskuil M, Schutgens RE. Cardiac catheterization and intervention in haemophilia patients: prospective evaluation of the 2009 institutional guideline. Haemophilia 2013; 19: 370-7.
18. Konkle B, Kessler C, Aledort L etal. Emerging clinical concerns in the ageing haemophilia patient. Haemophilia 2009; 15: 1197-209.
19. Fransen van de Putte DE, Fischer K, Makris M etal. History of non-fatal cardiovascular disease in a cohort of Dutch and British patients with haemophilia. Eur J Haematol 2012; 89: 336-9.
20. Fransen van de Putte DE, Fischer K, Pulles AE etal. Non-fatal cardiovascular disease, malignancies, and other co-morbidity in adult haemophilia patients. Thromb Res 2012; 130: 157-62.
21. Fransen van de Putte DE, Fischer K, Makris M etal. Unfavourable cardiovascular disease risk profiles in a cohort of Dutch and British haemophilia patients. Thromb Haemost 2013; 109: 16-23.
22. von Drygalski A, Kolaitis NA, Bettencourt R etal. Prevalence and risk factors for hypertension in hemophilia. Hypertension 2013; 62: 209-15.
23. Wong TE, Majumdar S, Adams E etal. Overweight and obesity in hemophilia: a systematic review of the literature. Am J Prev Med 2011; 41: S369-75.